or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    GH B 0.42 2.11
    NTRA A -0.23 2.02
    CRL D 0.80 1.94
    ISRG A 0.74 1.92
    ILMN C 1.19 1.92
    INCY C -1.58 1.91
    PEN B -0.61 1.88
    SYK A 0.42 1.82
    BSX A 0.99 1.79
    VRTX D -0.65 1.76
    VCYT B 0.51 1.73
    AXGN D 1.71 1.72
    CRSP D -2.45 1.69
    RVTY D 2.46 1.69
    IRTC C -0.19 1.67
    MASI B 1.66 1.65
    TWST F 0.15 1.58
    AORT B 0.88 1.56
    CTLT D 0.39 1.54
    DHR D -0.69 1.52
    STAA F -0.38 1.51
    NVCR C -1.42 1.50
    ARWR D -1.87 1.50
    MEDP F 2.55 1.50
    TMO D -0.58 1.49
    BMY B -0.05 1.45
    IART C -0.17 1.44
    EW C 0.65 1.44
    NOVT D 0.51 1.44
    BIO C -0.29 1.42
    GKOS A 0.87 1.42
    UTHR C 0.09 1.41
    QGEN D 0.34 1.41
    ABT B -0.30 1.41
    A F 2.24 1.40
    OMCL C 2.44 1.40
    AZTA D 2.82 1.38
    GMED A 0.17 1.37
    IQV F 0.40 1.36
    ALGN D 0.98 1.33
    DXCM C -1.17 1.32
    GEHC C -0.93 1.31
    HOLX D 0.83 1.25
    BDX F 0.16 1.22
    VEEV C 1.50 1.21
    CNMD C 0.25 1.14
    REGN F -0.14 1.13
    FLGT F 0.72 1.12
    CDNA D -0.40 1.10
    EXAS D 1.67 1.09
    HCAT F 0.00 0.99
    MRNA F -0.22 0.97
    BMRN F -0.97 0.92
    ALNY D 0.24 0.92
    BAX F 0.72 0.88

    Represented by ETF Holdings

    Keywords: Medicine S&P 500 Biotechnology Cancer Lab Testing Nasdaq 100 Biopharmaceutical Clinical Medicine Life Sciences Telemedicine Telehealth Acid Biology Medical Technology Clinical Development Infectious Diseases Bone Catheter Diabetes Gene Expression
    Industries: Diagnostics & Research Medical Devices Biotechnology Medical Instruments & Supplies Health Information Services Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services Scientific & Technical Instruments Semiconductor Equipment & Materials

    Recent News for Robo Global Healthcare Technology and Innovation ETF & its Holdings

    Date Stock Title
    Nov 21 ABT Major companies that are also popular short-selling stocks
    Nov 21 GMED ALGN Stock to Gain From CE Mark Win for Invisalign Palatal Expander
    Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
    Nov 21 VEEV Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and Claims
    Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
    Nov 21 GEHC GE HealthCare reiterates annual outlook, lifts dividend
    Nov 21 GEHC GE HealthCare Technologies raises dividend to $0.035/share
    Nov 21 GMED GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects
    Nov 21 GEHC GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
    Nov 21 VEEV Veeva on supporting the data burden in the life sciences sector
    Nov 21 BAX New Strong Sell Stocks for November 21st
    Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
    Nov 20 GMED These 19 stocks are poised for tax reform turbocharge - Jefferies
    Nov 20 ILMN Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
    Nov 20 IRTC iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
    Nov 20 PEN Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
    Nov 20 A Agilent Technologies increases dividend by ~5% to $0.248
    Nov 20 A Agilent Increases Cash Dividend to 24.8 Cents per Share
    Nov 20 ALGN Align Technology Has Received CE Mark in Europe for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients
    Nov 20 ILMN If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer
    The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies products and services. It is non-diversified.
    Exchange Traded Fund Index Fund Investment Management Healthcare Technology
    Back to the Main HTEC Page...